Lv1
48 积分 2025-03-24 加入
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2天前
已完结
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2天前
已完结
Current Management of Desmoid Tumors
17天前
已完结
中国狼疮肾炎诊治和管理指南（2025版）
18天前
已完结
Systemic lupus erythematosus
24天前
已完结
Global epidemiology of rheumatoid arthritis
1个月前
已完结
2024中国类风湿关节炎诊疗指南
1个月前
已完结
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
1个月前
已完结
Ⅰ期临床试验中健康参与者安全性管理的专家共识
2个月前
已关闭
皖公网安备34019202002308
